Motor Neurone Disease: NSW Mandates Reporting as Regional Mortality Rates Rise
NSW has become the first jurisdiction in Australia to mandate doctor reporting of all new motor neurone disease (MND) diagnoses, as new research reveals significantly higher death rates in regional and agricultural areas.
Mandatory Reporting in NSW
The NSW government has mandated that doctors report all diagnoses of motor neurone disease to a state registry. This change took effect immediately, making NSW the first jurisdiction to implement such a requirement.
Registry Details
- The registry will collect data on patients' location and occupation
- Information is intended to aid researchers in investigating potential genetic and environmental causes
- Previously, Australia relied on a voluntary national registry, which experts described as yielding unreliable data
"The registry will help provide a clearer picture of MND and its potential causes." — NSW Health Minister Ryan Park
Professor Dominic Rowe, head of neurology at Macquarie University, said the change enables systematic research into environmental causes of MND. Keri Balding, whose sister Jennifer died from MND, welcomed the decision as "a step in the right direction."
Why This Matters
- Approximately 90% of MND cases are sporadic, meaning they occur without a family history
- Calls for mandatory reporting intensified following reports of MND clusters near blue-green algae outbreaks and in areas with higher exposure to agricultural chemicals
- Communities near Lake Illawarra and along the NSW Riverina have reportedly recorded MND rates nearly seven times the national average
Geographic Mortality Trends
A study led by Macquarie University analyzed MND mortality data between 2019 and 2023, revealing higher rates in regional areas compared to major cities.
Key Data
- MND kills approximately 800 Australians annually
- Since the 1980s, MND mortality has tripled, from 238 deaths in 1986 to 781 in 2023
- Nationwide, approximately 1 in 200 Australians die from MND each year
- Compared to NSW, Tasmania recorded 1.4 times the number of deaths, and South Australia recorded 1.2 times
- Residents of regional areas show a 40% higher risk of developing the condition in some analyses
Potential Contributing Factors
While the study did not definitively identify causes, Professor Dominic Rowe noted the correlation between higher mortality and regions with intensive agriculture, including viticulture in South Australia and orchard industries in Tasmania.
"Insecticides are chemicals designed to kill motor neurons." — Professor Dominic Rowe
The study suggested a potential link to cumulative exposure to agricultural chemicals, including insecticides.
NRL Player Diagnosed
South Sydney Rabbitohs forward Jai Arrow, 30, has been diagnosed with MND, ending his NRL career.
This case adds to the context where the link between head injuries and MND is being studied. Professor Dominic Rowe stated that head injury alone does not cause MND, but it may disrupt the blood-brain barrier, potentially increasing susceptibility to environmental toxins. A 2022 New Zealand study found an association between repeated concussion and an increased MND risk.
Patient Experiences
Individuals diagnosed with MND have reported significant challenges associated with the disease and the diagnostic process.
Kelli Skipper, diagnosed with progressive bulbar palsy (a form of MND) in regional Australia, reported significant difficulties in obtaining a diagnosis. Her diagnosis followed 18 months of tests requiring extensive travel and out-of-pocket expenses.
Simon Downes, 68, was diagnosed with MND in 2024 after 30 years of dairy farming in NSW's Hunter Valley. He experiences limited mobility in his right arm.
Understanding Motor Neurone Disease
What is MND?
- A class of diseases affecting motor neurons, which transmit signals from the brain to muscles to enable movement
- Symptoms include muscle weakness and wasting
Key Statistics
- Approximately 800 Australians are diagnosed with MND annually
- 10% of cases are due to genetic mutations; 90% are sporadic
- Average survival is 2.5 years, though 5-10% of patients survive over 10 years
Treatment
- There is no cure for sporadic MND
- Treatment focuses on improving quality of life and extending life expectancy
- A therapy for the SOD1 genetic mutation shows promise